Long-term treatment with a new repeatable injectable form of bromocriptine, Parlodel LAR, in patients with tumorous hyperprolactinemia.

Long-term treatment with a new repeatable injectable form of bromocriptine, Parlodel LAR, in patients with tumorous hyperprolactinemia.

A new long-acting repeatable injectable form of bromocriptine, (Parlodel LAR, Sandoz, Basle, Switzerland) has recently been developed. We studied the clinical, hormonal and radiological changes in six female patients with microprolactinomas and eight (3 female and 5 male) with macroprolactinomas rec...

पूर्ण विवरण

ग्रंथसूची विवरण
मुख्य लेखकों:	Ciccarelli, E, Miola, C, Avataneo, T, Camanni, F, Besser, G, Grossman, A
स्वरूप:	Journal article
भाषा:	English
प्रकाशित:	1989

समान संसाधन

Acute and long-term effects of once-daily oral bromocriptine and a new long-acting non-ergot dopamine agonist, quinagolide, in the treatment of hyperprolactinemia: a double-blind study.
द्वारा: Verhelst, J, और अन्य
प्रकाशित: (1991)

Terguride--a new dopamine agonist drug: a comparison of its neuroendocrine and side effect profile with bromocriptine.
द्वारा: Ciccarelli, E, और अन्य
प्रकाशित: (1988)

DEPOT BROMOCRIPTINE IN THE TREATMENT OF PROLACTINOMAS AND ACROMEGALY
द्वारा: Grossman, A, और अन्य
प्रकाशित: (1985)

Depot-bromocriptine treatment for prolactinomas and acromegaly.
द्वारा: Grossman, A, और अन्य
प्रकाशित: (1986)

The rapid diagnosis of sensitivity or resistance to dopamine agonists with depot bromocriptine.
द्वारा: Grossman, A, और अन्य
प्रकाशित: (1987)

Oral prednisolone supplement abolishes the acute adverse effects following initiation of depot bromocriptine therapy.
द्वारा: Jenkins, P, और अन्य
प्रकाशित: (1996)

A bromocriptine-responsive corticotroph adenoma secreting alpha-MSH in a patient with Cushing's disease.
द्वारा: Hale, A, और अन्य
प्रकाशित: (1988)

OVARIAN AND UTERINE CHANGES INDUCED BY BROMOCRIPTINE INJECTION TO PSEUDOPREGNANT RATS
द्वारा: A. A.J. Flaih, और अन्य
प्रकाशित: (1988-12-01)

Effects of bromocriptine on serum prolactin levels, pituitary weight and immunoreactive prolactin cells in estradiol-treated ovariectomized rats: an experimental model of estrogen-dependent hyperprolactinemia
द्वारा: M.F. Ribeiro, और अन्य
प्रकाशित: (1997-01-01)

Agonisty dofamina - parlodel, norprolak i dostineks v korrektsii narusheniy reproduktivnoy sistemy u patsientok s prolaktinomami gipofiza
द्वारा: A A Osipova
प्रकाशित: (2001-08-01)

Cabergoline or bromocriptine for prolactinoma?
द्वारा: Nicolás Triantafilo, और अन्य
प्रकाशित: (2016-09-01)

Hyperprolactinemia
द्वारा: Abha Majumdar, और अन्य
प्रकाशित: (2013-01-01)

Central Hyperthermia Treated with Bromocriptine
द्वारा: P. Natteru, और अन्य
प्रकाशित: (2017-01-01)

Bromocriptine in the Management of Central Hyperthermia
द्वारा: Krishnaprasad Narayanankutty, और अन्य
प्रकाशित: (2024-08-01)

Repurposing of Bromocriptine for Cancer Therapy
द्वारा: Ean-Jeong Seo, और अन्य
प्रकाशित: (2018-10-01)

The Effect of Bromocriptine Injection on Ovarieres and Uteri Through Early Pregnant Stages in Albino Mice
द्वारा: A. S . AL- Janabi, और अन्य
प्रकाशित: (2017-08-01)

Bromocriptine for type 2 diabetes mellitus
द्वारा: Ooi, Cheow Peng, और अन्य
प्रकाशित: (2013)

Bromocriptine in type 2 diabetes mellitus
द्वारा: C Shivaprasad, और अन्य
प्रकाशित: (2011-01-01)

The Effect of Fluvoxamine on Sex Hormone Levels and Ovarian Histology in Trichogaster trichopterus after Bromocriptine Injection
द्वारा: SH Rashidpour, और अन्य
प्रकाशित: (2020-12-01)

Editorial: Insights in hyperprolactinemia
द्वारा: Maria M. Pineyro, और अन्य
प्रकाशित: (2024-01-01)

Antipsychotic-induced Hyperprolactinemia
द्वारा: Suheyla Dogan Bulut, और अन्य
प्रकाशित: (2015-06-01)

Drug induced hyperprolactinemia
द्वारा: M. H. Wattegama, और अन्य
प्रकाशित: (2017-10-01)

Hyperprolactinemia in women: treatment
द्वारा: Cristina Laguna Benetti-Pinto, और अन्य
प्रकाशित: (2024-05-01)

Utility of Cannulated Prolactin to Exclude Stress Hyperprolactinemia in Patients with Persistent Mild Hyperprolactinemia
द्वारा: Raya Almazrouei, और अन्य
प्रकाशित: (2021-06-01)

Lar, doce lar?
द्वारा: Silvia Scoralich de Carvalho
प्रकाशित: (2023-08-01)

Bromocriptine use is associated with decreased smoking rates.
द्वारा: Murphy, M, और अन्य
प्रकाशित: (2002)

A peripartum cardiomyopathy case treated with bromocriptine
द्वारा: Dilek Yeşilbursa, और अन्य
प्रकाशित: (2021-03-01)

Bromocriptine and insulin sensitivity in lean and obese subjects
द्वारा: L Bahler, और अन्य
प्रकाशित: (2016-11-01)

Bromocriptine Use in Peripartum Cardiomyopathy: Review of Cases
द्वारा: Rebecca Simon, और अन्य
प्रकाशित: (2018-10-01)

Neuroleptic hyperprolactinemia medicamentous correction
द्वारा: L. N. Gorobets, और अन्य
प्रकाशित: (2018-07-01)

Evolution of pregnancy planning in hyperprolactinemia
द्वारा: L. K. Dzeranova, और अन्य
प्रकाशित: (2024-08-01)

Clinical guidelines ‘Hyperprolactinemia’ (draft)
द्वारा: I. I. Dedov, और अन्य
प्रकाशित: (2023-07-01)

Etiopathogenetic features of hyperprolactinemia in childhood
द्वारा: O.E. Abaturov, और अन्य
प्रकाशित: (2021-12-01)

Contemporary approaches to the diagnosis of hyperprolactinemia
द्वारा: О. А. Бурка, और अन्य
प्रकाशित: (2019-12-01)

Lurasidone-induced parkinsonism and hyperprolactinemia
द्वारा: Navratan Suthar, और अन्य
प्रकाशित: (2019-01-01)

Laboratory Aspects of Hyperprolactinemia Diagnosis
द्वारा: O.V. Rykova
प्रकाशित: (2015-05-01)

Hyperprolactinemia in the postmenopause: versions and contraversions
द्वारा: Olga Ya. Leshchenko
प्रकाशित: (2021-10-01)

Hyperprolactinemia in women: diagnostic approach
द्वारा: Andrea Glezer, और अन्य
प्रकाशित: (2024-05-01)

A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea
द्वारा: Ismail, I.S., और अन्य
प्रकाशित: (1994)

EFFECT OF OXYTOCIN AND BROMOCRIPTINE ON CORPORA LUTEA AND PSEUDOPREGNANCY IN MICE
द्वारा: N. A. S. AL- Khadi, और अन्य
प्रकाशित: (1990-12-01)